Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis

Mijung Kwon, Soo Jin Lee, Yarong Wang, Yevangelina Rybak, Alex Luna, Srilakshmi Reddy, Asha Adem, Brian T. Beaty, John S. Condeelis, Steven K. Libutti

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Identifying key mediators of cancer invasion and metastasis is crucial to the development of new and more effective therapies. We previously identified FILamin A Interacting Protein 1-Like (FILIP1L) as an important inhibitor of cell migration and invasion. FILIP1L expression was inversely correlated with the invasive potential of ovarian tumors. In our study, we established an orthotopic ovarian cancer model, wherein FILIP1L expression can be regulated in vivo. Using this model, we observed that expression of FILIP1L in ovarian cancer cells inhibited spontaneous lung metastasis. Experimental lung metastases (established via tail vein injection of cancer cells) as well as the extravasation step of metastasis were not inhibited by FILIP1L, suggesting that FILIP1L inhibits the earlier steps of metastasis such as invasion and intravasation. FILIP1L inhibited matrix metalloproteinase (MMP)-dependent invasion in vivo. MMP3, -7 and -9 were transcriptionally downregulated, and MMP9 protein expression and activity were inhibited in FILIP1L-expressing tumors. Importantly, overexpression of MMP9 compensated for the anti-invasive activity of FILIP1L. Furthermore, our studies suggest that FILIP1L regulates invasion and metastasis by inhibiting components of the WNT signaling pathway. FILIP1L expression reduced the induction of WNT target genes such as MMP3, -7 and -9, and β-catenin-directed transcriptional activity, suggesting inhibition of the canonical WNT pathway. Nuclear β-catenin, an indicator of an active canonical WNT pathway, was reduced in FILIP1L-expressing tumors. Overall, these findings suggest that FILIP1L reduces β-catenin levels, which may lead to the transcriptional downregulation of WNT target genes such as MMPs, resulting in inhibition of metastasis. Modulation of FILIP1L expression has the potential to be a target for cancer therapy. What's new? A critical first step in cancer metastasis is invasion, the inhibition of which could lead to the development of new cancer therapies. In the present study, a previously identified inhibitor of cancer metastasis, filamin A interacting protein 1-like (FILIP1L), is shown to block early steps of metastasis, including invasion and intravasation, in a doxycycline-inducible ovarian orthotopic mouse model. Mechanistic evaluation suggests that FILIP1L inhibits metastasis through blockade of WNT signaling. The findings indicate that FILIP1L may be a target for the development of novel cancer therapeutics.

Original languageEnglish (US)
Pages (from-to)48-60
Number of pages13
JournalInternational Journal of Cancer
Volume135
Issue number1
DOIs
StatePublished - Jul 1 2014

Fingerprint

Filamins
Matrix Metalloproteinases
Neoplasm Metastasis
Neoplasms
Proteins
Catenins
Ovarian Neoplasms
Down-Regulation

Keywords

  • FILIP1L
  • invasion
  • metastasis
  • MMP
  • WNT

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis. / Kwon, Mijung; Lee, Soo Jin; Wang, Yarong; Rybak, Yevangelina; Luna, Alex; Reddy, Srilakshmi; Adem, Asha; Beaty, Brian T.; Condeelis, John S.; Libutti, Steven K.

In: International Journal of Cancer, Vol. 135, No. 1, 01.07.2014, p. 48-60.

Research output: Contribution to journalArticle

Kwon, Mijung ; Lee, Soo Jin ; Wang, Yarong ; Rybak, Yevangelina ; Luna, Alex ; Reddy, Srilakshmi ; Adem, Asha ; Beaty, Brian T. ; Condeelis, John S. ; Libutti, Steven K. / Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis. In: International Journal of Cancer. 2014 ; Vol. 135, No. 1. pp. 48-60.
@article{ea270bada38d4423ad6cbf9584c56a63,
title = "Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis",
abstract = "Identifying key mediators of cancer invasion and metastasis is crucial to the development of new and more effective therapies. We previously identified FILamin A Interacting Protein 1-Like (FILIP1L) as an important inhibitor of cell migration and invasion. FILIP1L expression was inversely correlated with the invasive potential of ovarian tumors. In our study, we established an orthotopic ovarian cancer model, wherein FILIP1L expression can be regulated in vivo. Using this model, we observed that expression of FILIP1L in ovarian cancer cells inhibited spontaneous lung metastasis. Experimental lung metastases (established via tail vein injection of cancer cells) as well as the extravasation step of metastasis were not inhibited by FILIP1L, suggesting that FILIP1L inhibits the earlier steps of metastasis such as invasion and intravasation. FILIP1L inhibited matrix metalloproteinase (MMP)-dependent invasion in vivo. MMP3, -7 and -9 were transcriptionally downregulated, and MMP9 protein expression and activity were inhibited in FILIP1L-expressing tumors. Importantly, overexpression of MMP9 compensated for the anti-invasive activity of FILIP1L. Furthermore, our studies suggest that FILIP1L regulates invasion and metastasis by inhibiting components of the WNT signaling pathway. FILIP1L expression reduced the induction of WNT target genes such as MMP3, -7 and -9, and β-catenin-directed transcriptional activity, suggesting inhibition of the canonical WNT pathway. Nuclear β-catenin, an indicator of an active canonical WNT pathway, was reduced in FILIP1L-expressing tumors. Overall, these findings suggest that FILIP1L reduces β-catenin levels, which may lead to the transcriptional downregulation of WNT target genes such as MMPs, resulting in inhibition of metastasis. Modulation of FILIP1L expression has the potential to be a target for cancer therapy. What's new? A critical first step in cancer metastasis is invasion, the inhibition of which could lead to the development of new cancer therapies. In the present study, a previously identified inhibitor of cancer metastasis, filamin A interacting protein 1-like (FILIP1L), is shown to block early steps of metastasis, including invasion and intravasation, in a doxycycline-inducible ovarian orthotopic mouse model. Mechanistic evaluation suggests that FILIP1L inhibits metastasis through blockade of WNT signaling. The findings indicate that FILIP1L may be a target for the development of novel cancer therapeutics.",
keywords = "FILIP1L, invasion, metastasis, MMP, WNT",
author = "Mijung Kwon and Lee, {Soo Jin} and Yarong Wang and Yevangelina Rybak and Alex Luna and Srilakshmi Reddy and Asha Adem and Beaty, {Brian T.} and Condeelis, {John S.} and Libutti, {Steven K.}",
year = "2014",
month = "7",
day = "1",
doi = "10.1002/ijc.28662",
language = "English (US)",
volume = "135",
pages = "48--60",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Filamin A interacting protein 1-like inhibits WNT signaling and MMP expression to suppress cancer cell invasion and metastasis

AU - Kwon, Mijung

AU - Lee, Soo Jin

AU - Wang, Yarong

AU - Rybak, Yevangelina

AU - Luna, Alex

AU - Reddy, Srilakshmi

AU - Adem, Asha

AU - Beaty, Brian T.

AU - Condeelis, John S.

AU - Libutti, Steven K.

PY - 2014/7/1

Y1 - 2014/7/1

N2 - Identifying key mediators of cancer invasion and metastasis is crucial to the development of new and more effective therapies. We previously identified FILamin A Interacting Protein 1-Like (FILIP1L) as an important inhibitor of cell migration and invasion. FILIP1L expression was inversely correlated with the invasive potential of ovarian tumors. In our study, we established an orthotopic ovarian cancer model, wherein FILIP1L expression can be regulated in vivo. Using this model, we observed that expression of FILIP1L in ovarian cancer cells inhibited spontaneous lung metastasis. Experimental lung metastases (established via tail vein injection of cancer cells) as well as the extravasation step of metastasis were not inhibited by FILIP1L, suggesting that FILIP1L inhibits the earlier steps of metastasis such as invasion and intravasation. FILIP1L inhibited matrix metalloproteinase (MMP)-dependent invasion in vivo. MMP3, -7 and -9 were transcriptionally downregulated, and MMP9 protein expression and activity were inhibited in FILIP1L-expressing tumors. Importantly, overexpression of MMP9 compensated for the anti-invasive activity of FILIP1L. Furthermore, our studies suggest that FILIP1L regulates invasion and metastasis by inhibiting components of the WNT signaling pathway. FILIP1L expression reduced the induction of WNT target genes such as MMP3, -7 and -9, and β-catenin-directed transcriptional activity, suggesting inhibition of the canonical WNT pathway. Nuclear β-catenin, an indicator of an active canonical WNT pathway, was reduced in FILIP1L-expressing tumors. Overall, these findings suggest that FILIP1L reduces β-catenin levels, which may lead to the transcriptional downregulation of WNT target genes such as MMPs, resulting in inhibition of metastasis. Modulation of FILIP1L expression has the potential to be a target for cancer therapy. What's new? A critical first step in cancer metastasis is invasion, the inhibition of which could lead to the development of new cancer therapies. In the present study, a previously identified inhibitor of cancer metastasis, filamin A interacting protein 1-like (FILIP1L), is shown to block early steps of metastasis, including invasion and intravasation, in a doxycycline-inducible ovarian orthotopic mouse model. Mechanistic evaluation suggests that FILIP1L inhibits metastasis through blockade of WNT signaling. The findings indicate that FILIP1L may be a target for the development of novel cancer therapeutics.

AB - Identifying key mediators of cancer invasion and metastasis is crucial to the development of new and more effective therapies. We previously identified FILamin A Interacting Protein 1-Like (FILIP1L) as an important inhibitor of cell migration and invasion. FILIP1L expression was inversely correlated with the invasive potential of ovarian tumors. In our study, we established an orthotopic ovarian cancer model, wherein FILIP1L expression can be regulated in vivo. Using this model, we observed that expression of FILIP1L in ovarian cancer cells inhibited spontaneous lung metastasis. Experimental lung metastases (established via tail vein injection of cancer cells) as well as the extravasation step of metastasis were not inhibited by FILIP1L, suggesting that FILIP1L inhibits the earlier steps of metastasis such as invasion and intravasation. FILIP1L inhibited matrix metalloproteinase (MMP)-dependent invasion in vivo. MMP3, -7 and -9 were transcriptionally downregulated, and MMP9 protein expression and activity were inhibited in FILIP1L-expressing tumors. Importantly, overexpression of MMP9 compensated for the anti-invasive activity of FILIP1L. Furthermore, our studies suggest that FILIP1L regulates invasion and metastasis by inhibiting components of the WNT signaling pathway. FILIP1L expression reduced the induction of WNT target genes such as MMP3, -7 and -9, and β-catenin-directed transcriptional activity, suggesting inhibition of the canonical WNT pathway. Nuclear β-catenin, an indicator of an active canonical WNT pathway, was reduced in FILIP1L-expressing tumors. Overall, these findings suggest that FILIP1L reduces β-catenin levels, which may lead to the transcriptional downregulation of WNT target genes such as MMPs, resulting in inhibition of metastasis. Modulation of FILIP1L expression has the potential to be a target for cancer therapy. What's new? A critical first step in cancer metastasis is invasion, the inhibition of which could lead to the development of new cancer therapies. In the present study, a previously identified inhibitor of cancer metastasis, filamin A interacting protein 1-like (FILIP1L), is shown to block early steps of metastasis, including invasion and intravasation, in a doxycycline-inducible ovarian orthotopic mouse model. Mechanistic evaluation suggests that FILIP1L inhibits metastasis through blockade of WNT signaling. The findings indicate that FILIP1L may be a target for the development of novel cancer therapeutics.

KW - FILIP1L

KW - invasion

KW - metastasis

KW - MMP

KW - WNT

UR - http://www.scopus.com/inward/record.url?scp=84899435397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899435397&partnerID=8YFLogxK

U2 - 10.1002/ijc.28662

DO - 10.1002/ijc.28662

M3 - Article

C2 - 24327474

AN - SCOPUS:84899435397

VL - 135

SP - 48

EP - 60

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 1

ER -